InfuSystem Holdings, Inc. (NYSE:INFU) Sees Significant Increase in Short Interest

InfuSystem Holdings, Inc. (NYSE:INFU - Get Free Report) was the target of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 508,000 shares, an increase of 27.1% from the May 15th total of 399,700 shares. Approximately 2.7% of the shares of the stock are short sold. Based on an average daily trading volume, of 149,400 shares, the days-to-cover ratio is currently 3.4 days.

InfuSystem Price Performance

Shares of INFU traded up $0.06 during trading hours on Friday, hitting $6.25. 220,323 shares of the stock were exchanged, compared to its average volume of 100,992. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98. InfuSystem has a 12-month low of $4.61 and a 12-month high of $9.97. The company has a market cap of $131.35 million, a price-to-earnings ratio of 104.18 and a beta of 1.81. The stock's 50-day moving average price is $5.52 and its two-hundred day moving average price is $6.70.

Institutional Trading of InfuSystem

Several large investors have recently made changes to their positions in the company. BNP Paribas Financial Markets increased its position in shares of InfuSystem by 67.9% during the fourth quarter. BNP Paribas Financial Markets now owns 6,844 shares of the company's stock worth $58,000 after purchasing an additional 2,768 shares in the last quarter. Barclays PLC grew its holdings in InfuSystem by 10.1% in the 4th quarter. Barclays PLC now owns 31,479 shares of the company's stock valued at $266,000 after buying an additional 2,882 shares in the last quarter. Wells Fargo & Company MN grew its holdings in InfuSystem by 51.7% in the 4th quarter. Wells Fargo & Company MN now owns 9,286 shares of the company's stock valued at $78,000 after buying an additional 3,165 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in InfuSystem by 4.7% in the 1st quarter. Bank of New York Mellon Corp now owns 95,471 shares of the company's stock valued at $514,000 after buying an additional 4,252 shares in the last quarter. Finally, Millennium Management LLC grew its holdings in InfuSystem by 6.3% in the 4th quarter. Millennium Management LLC now owns 76,419 shares of the company's stock valued at $646,000 after buying an additional 4,532 shares in the last quarter. 71.13% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have recently weighed in on INFU shares. Sidoti raised InfuSystem to a "strong-buy" rating in a research note on Tuesday, March 18th. Wall Street Zen cut InfuSystem from a "strong-buy" rating to a "buy" rating in a research report on Wednesday, May 14th. Finally, B. Riley upgraded InfuSystem to a "strong-buy" rating in a research report on Thursday, May 8th.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.